Association Between Obstructive Sleep Apnea-Hypopnea Syndrome and Outcomes in Patients with Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease

Chao‐Jie He, Linfeng Cao, Chunyan Zhu, Yujuan Zhu, Shijun Wang, Changlin Zhai, Huilin Hu

Abstract

Background: Myocardial infarction in the absence of obstructive coronary artery disease (MINOCA) occurs in 5% to 10% of all patients with acute myocardial infarction. Obstructive sleep apnea-hypopnea syndrome (OSAHS) is linked to increased cardiovascular morbidity and mortality, but the relationship of OSAHS and outcomes in patients with MINOCA remains unknown. Objectives: We aimed to evaluate the association between OSAHS and clinical outcomes in patients with MINOCA. Methods and Results: Between January 2015 and December 2016, we carried out a prospective and consecutive cohort study of 583 patients with MINOCA and followed them up for three years. An apnea-hypopnea index (AHI) of ≥15 events per hour recorded by polysomnography was defined as the diagnostic criterion for OSAHS. The primary end point was all-cause mortality, and the second end point was major adverse cardiovascular or cerebrovascular events (MACCE). All-cause mortality happened in 69 patients and MACCE occurred in 113 patients during the three-year follow-up. Multivariate Cox regression analysis indicated OSAHS as an independent predictor of all-cause mortality and MACCE. Conclusions: OSAHS is independently associated with increased risk of all-cause mortality and MACCE in patients with MINOCA.

Introduction

Myocardial infarction in the absence of obstructive coronary artery disease (MINOCA) accounts for 5% to 10% of all heart attacks. It is a distinct condition where patients suffer a heart attack despite coronary angiography showing no significant artery blockages (less than 50% stenosis). While Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS) is a recognized risk factor for traditional coronary artery disease—contributing to systemic inflammation and hypertension—its prevalence and prognostic impact on MINOCA patients have been largely unexplored. This study investigates whether MINOCA patients suffer from high rates of OSAHS and if untreated sleep apnea worsens their long-term clinical outcomes.

Methods

This prospective cohort study followed 583 MINOCA patients for three years at the First Affiliated Hospital of Jiaxing University. To ensure diagnostic accuracy, researchers used overnight polysomnography (PSG), the gold standard sleep study, for all participants. OSAHS was defined by an Apnea-Hypopnea Index (AHI) of ≥ 15 events per hour.

Baseline characteristics of the study cohort divided by OSAHS status.

The primary endpoint was all-cause mortality, while the secondary endpoint was Major Adverse Cardiovascular or Cerebrovascular Events (MACCE), including cardiac death, nonfatal heart attacks, heart failure, stroke, and cardiovascular rehospitalization. Multivariate Cox proportional hazards models were used to isolate the effect of OSAHS from other confounding variables.

Results

Out of the 583 patients, 158 (27.1%) were diagnosed with OSAHS. The sleep study metrics clearly differentiated the two groups, with the OSAHS group showing significantly higher AHI and lower oxygen saturation levels compared to the control group.

Sleep study parameters and Berlin Questionnaire results for the study groups.

Over the 3-year follow-up, 69 deaths and 113 MACCE events occurred. Key findings include:

  • Prevalence: OSAHS is common in MINOCA patients (27.1%), suggesting sleep-disordered breathing is a major physiological stressor even without traditional artery blockages.
  • Mortality Risk: Patients with OSAHS had a 1.714 times higher risk of all-cause mortality (Adjusted HR: 1.714, 95% CI: 1.203–2.168, p=0.013).
  • MACCE Risk: OSAHS patients faced a 1.787 times higher risk of major adverse events (Adjusted HR: 1.787, 95% CI: 1.249–2.236, p=0.004).
  • Screening Gaps: The Berlin Questionnaire only identified 70.9% of confirmed OSAHS cases, indicating that self-reported tools may miss many at-risk patients.

Conclusion

OSAHS is an independent predictor of death and severe cardiovascular events in patients with MINOCA. The physiological stress caused by sleep apnea—such as intermittent hypoxia and sympathetic activation—likely drives this elevated risk. These findings highlight the critical need for clinical screening using polysomnography in MINOCA patients. Future randomized trials should investigate whether interventions like Continuous Positive Airway Pressure (CPAP) therapy can mitigate these risks and improve long-term survival in this population.

Summary updated

Abstract

<title>Abstract</title> <bold>Background: </bold>Myocardial infarction in the absence of obstructive coronary artery disease (MINOCA) occurs in 5% to 10% of all patients with acute myocardial infarction. Obstructive sleep apnea-hypopnea syndrome (OSAHS) is linked to increased cardiovascular morbidity and mortality, but the relationship of OSAHS and outcomes in patients with MINOCA remains unknown. <bold>Objectives: </bold>We aimed to evaluate the association between OSAHS and clinical outcomes in patients with MINOCA.<bold>Methods and Results: </bold>Between January 2015 and December 2016, we carried out a prospective and consecutive cohort study of 583 patients with MINOCA and followed them up for three years. An apnea-hypopnea index of ≥15 events per hour recorded by polysomnography was defined as the diagnostic criterion for OSAHS. The primary end point was all-cause mortality, and the second end point was major adverse cardiovascular or cerebrovascular events (MACCE), a composite of cardiac death, nonfatal myocardial infarction, heart failure, cardiovascular-related rehospitalization, and stroke. All-cause mortality happened in 69 patients and MACCE occurred in 113 patients during the three-year follow-up. Kaplan–Meier survival curves indicated the significant relationship of OSAHS with all-cause mortality (log-rank P = 0.012) and MACCE (log-rank P = 0.002). Multivariate Cox regression analysis indicated OSAHS as an independent predictor of all-cause mortality and MACCE (adjusted hazard ratio: 1.714; 95% confidence interval (CI): 1.203–2.168; P = 0.013; and adjusted hazard ratio: 1.787; 95% CI: 1.249–2.236; P = 0.004; respectively), independent of age, sex, cardiovascular risk factors and discharge medications.<bold>Conclusions:</bold> OSAHS is independently associated with increased risk of all-cause mortality and MACCE in patients with MINOCA. Intervention and treatment should be considered to alleviate OSAHS-associated risk.
BibTeX
@inproceedings{he2020association,
  author = {Chao‐Jie He and Linfeng Cao and Chunyan Zhu and Yujuan Zhu and Shijun Wang and Changlin Zhai and Huilin Hu},
  title = {{Association Between Obstructive Sleep Apnea-Hypopnea Syndrome and Outcomes in Patients with Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease}},
  booktitle = {Frontiers in Cardiovascular Medicine},
  year = {2020},
  doi = {10.3389/fcvm.2020.573819},
}
Figure